• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

AMCP names 4 new members to board


The Academy of Managed Care Pharmacy recently installed 4 new members to its board of directors. The new board members were sworn in April 29 at AMCP?s 23rd Annual Meeting & Showcase in Minneapolis.

The Academy of Managed Care Pharmacy (AMCP) recently installed 4 new members to its board of directors.  The new board members were sworn in April 29 at AMCP’s 23rd Annual Meeting & Showcase in Minneapolis.

Doug Burgoyne, president-elect and a board member for the past 2 years, is president of VRX Pharmacy Services.  Prior to this position, Burgoyne served on 3 committees-Legislative, Membership, and Program Planning and Development, where he served as committee chair.  He believes the most compelling managed care issues over the next 5 years are healthcare reform and successfully managing high-cost specialty drugs, including follow-on biologics.

“Managed care pharmacists will need to collaborate with other providers and creatively develop management strategies that maintain affordability of care in a new world,” Burgoyne said.

Robert Gregory, treasurer, is pharmacy director for Aetna Pharmacy Management.  He has more than 30 years of experience as a practicing pharmacist and healthcare manager.  Gregory seeks to promote diversity and inclusion throughout AMCP.

“Leadership and staff must continue to search out additional opportunities whether they be selling services or developing additional products,” Gregory said.  “It must be able to leverage the diversity of members and the strength of the brand with key external markets and communities.”

Steven G. Avey, board of director, is vice president of national sales, RegenceRx. He served 5 years as the executive director of the Foundation for Managed Care Pharmacy.  Avey believes the most compelling factor facing managed care pharmacy over the next 5 years is the large influx of insured Americans being enrolled in government programs. 

“Managed care pharmacists will be asked to ensure that each health plan or PBM is paying for the most appropriate medication from a clinical and cost perspective,” Avey said.

H. Eric Cannon, board of director, is chief of pharmacy services at SelectHealth, an Intermountain Healthcare Company.  He was vice chair of the AMCP Organizational Affairs Committee, and served on the Legislative Committee as both a member and chair.

Cannon said AMCP has a responsibility to help and provide counsel during the implementation of the Accountable Care Act.  “Health reform will touch all of the members of AMCP in one way or another,” Cannon added.  “All of the AMCP membership will be affected by the guidelines and standards set in place by the federal government.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.